APELLIS PHARMACEUTICALS INC
CUSIP 03753UAB2
Apellis Pharmaceuticals Inc has 7 institutional holders in Filings Flow’s 13F database, together reporting 93.84M shares worth $99M as of Q1 2026. The largest reported holders are Deepcurrents Investment Group LLC, Linden Advisors LP, and Tenor Capital Management Co., L.P..
Institutional Holders
7
Q1 2026
Reported Value
$99M
Ticker
unmapped
private placement or foreign
Quarters Tracked
5
Ownership Trend
Institutional holders
Total reported value
Holders
Mixed quarters
| Manager | % of Portfolio | Value | Shares | Quarter |
|---|---|---|---|---|
| DeepCurrents Investment Group LLC$3.1B AUM | 1.51% | $47M | 44.49M | Q1 2026 |
| TENOR CAPITAL MANAGEMENT Co., L.P.$6.5B AUM | 0.20% | $13M | 11.95M | Q1 2026 |
| LINDEN ADVISORS LP$17.9B AUM | 0.17% | $30M | 28.14M | Q1 2026 |
| WOLVERINE ASSET MANAGEMENT LLC$10.4B AUM | 0.03% | $3M | 3.12M | Q1 2026 |
| CANTOR FITZGERALD, L. P.$6.8B AUM | 0.02% | $1M | 1.13M | Q1 2026 |
| KORNITZER CAPITAL MANAGEMENT INC /KS$4.6B AUM | 0.01% | $308,062 | 300.0K | Q4 2025OLDER |
| D. E. Shaw & Co., Inc.$166.3B AUM | 0.00% | $5M | 5.00M | Q1 2026 |
| WELLINGTON MANAGEMENT GROUP LLP$535.5B AUM | 0.00% | $1M | 1.13M | Q4 2025OLDER |
| CITIGROUP INC$234.5B AUM | 0.00% | $6,300 | 6.0K | Q1 2026 |
Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.